Correlation Between Denali Therapeutics and Onconova Therapeutics
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Onconova Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Onconova Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Onconova Therapeutics, you can compare the effects of market volatilities on Denali Therapeutics and Onconova Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Onconova Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Onconova Therapeutics.
Diversification Opportunities for Denali Therapeutics and Onconova Therapeutics
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Denali and Onconova is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Onconova Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Onconova Therapeutics and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Onconova Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Onconova Therapeutics has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Onconova Therapeutics go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Onconova Therapeutics
If you would invest 2,077 in Denali Therapeutics on September 5, 2024 and sell it today you would earn a total of 293.00 from holding Denali Therapeutics or generate 14.11% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 0.8% |
Values | Daily Returns |
Denali Therapeutics vs. Onconova Therapeutics
Performance |
Timeline |
Denali Therapeutics |
Onconova Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Denali Therapeutics and Onconova Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Denali Therapeutics and Onconova Therapeutics
The main advantage of trading using opposite Denali Therapeutics and Onconova Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Onconova Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Onconova Therapeutics will offset losses from the drop in Onconova Therapeutics' long position.Denali Therapeutics vs. Candel Therapeutics | Denali Therapeutics vs. Cingulate Warrants | Denali Therapeutics vs. Unicycive Therapeutics | Denali Therapeutics vs. Cardio Diagnostics Holdings |
Onconova Therapeutics vs. Jaguar Animal Health | Onconova Therapeutics vs. Ibio Inc | Onconova Therapeutics vs. GeoVax Labs | Onconova Therapeutics vs. Ocugen Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |